HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK Royal Commission on nano

This article was originally published in The Rose Sheet

Executive Summary

There is no evidence of environmental or health risks from nanomaterials, and thus no need for a ban or moratorium against nanotechnology, the U.K.'s Royal Commission on Environmental Pollution says in a report published Nov. 12. However, the independent advisory panel calls for more testing on the functionality of nanoparticles, the immediate establishment of a research program and more flexibility in government to address nanotechnology and other nascent fields. Sir John Lawton, commission chair, calls for extending the coverage of the EU's REACH chemical regulation to nanomaterials, as "the rate of innovation in this sector far outstrips our capacity to respond to the risks." The European Commission has advised EU members to refrain from research on nanoparticles in food and personal care items until more risk assessments are completed (1"The Rose Sheet" Feb. 18, 2008, p. 6)

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015800

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel